Target intelligence / Profile preview

Complement Component 9 (C9)

Target: C9
Molecular classification: Protein, Membrane Attack Complex/Perforin superfamily

Overview

Complement component 9 (C9) is a terminal protein of the complement system, crucial for the innate immune response. It polymerizes to form transmembrane pores in target cells as part of the membrane attack complex (MAC), leading to cell lysis and death. C9 deficiency increases susceptibility to Neisseria meningitidis infections.

Other names: ARMD15C9Dcomplement component 9complement C9

Biological functions

Immune responseCell lysisPore formation

Disease associations

InfectionImmunodeficiency

Safety considerations

Increased susceptibility to Neisseria meningitidis infections in deficient individualsPotential for off-target effects if targeted therapeutically, given its role in immune defense

Beyond the preview

Go deeper on Complement Component 9 (C9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complement Component 9 (C9).